Added to YB: 2022-09-07
Pitch date: 2022-09-07
IMRA [bullish]
IMARA Inc.
+219.19%
current return
Author Info
Clark Street Value is a special sits/event-driven investor. Sign up for the newsletter.
Upgrade to Yellowbrick Premium to unlock investor returns. Upgrade to Yellowbrick Premium
Company Info
As of February 23, 2023, IMARA Inc. was acquired by Enliven Therapeutics, Inc., in a reverse merger transaction.
Market Cap
$165.8M
Pitch Price
$7.92
Price Target
N/A
Dividend
N/A
EV/EBITDA
-2.31
P/E
111.65
EV/Sales
N/A
Sector
Pharmaceuticals
Category
N/A
Show full summary:
IMARA: Asset Sale, Below NCAV, Potential Liquidation
A summary for this pitch has not been created yet.
Read full article (1 min)